Merck, the FDA, and the Vioxx Recall 1. Do you believe that Merck acted in a socially responsible and ethical manner with regard to Vioxx? Why or Why not? In your answer, please address the company’s drug development and testing, marketing and advertising, relationships with government regulators and policymakers, and handling of the recall. I do not believe that Merck made a socially responsible decision when Vioxx was introduced into the pharmaceutical market. Scientists that were involved in product development and testing knew that there were serious health risks that could be side effects of the medication- such as cardiovascular complications. If they considered the lives that could have potentially been and as we know now …show more content…
Additionally, further testing should have gone into analyzing the cause for the increased heart attacks. The majority of medications in the market, at times, have worse side effects than the initial ailment. I think more time could have possible been taken during the clinical trials with an end to reduce the cause for heart attacks. My grandmother was a user of Vioxx for many years and has never presented any of the side effects listed- Vioxx was actually very useful to her for her arthritis related inflammation. 3. What is the best way for society to protect consumers of prescription medicines? Specially, what are the appropriate roles for pharmaceutical companies, government regulators and policymakers, patients and their physicians, and the court system in assuring the safety and effectiveness of prescription medicines? Society’s role in protecting the consumers of prescription medicines is to actively play a role in the process that pharmaceutical companies follow when developing, testing and releasing new prescription meds into the market. All medication has side effects that issue warnings about what the medication can cause to your being. Physicians and patients need to both play an important role in giving the correct symptoms and doctors reading and diagnosing the patients symptoms. Doctors need to prescribe the correct medication to patients and should be very familiar with that medicine’s possible
The pharmaceutical industry is one of the most powerful and greedy industries in our country, with a goal to make as large a profit as possible, at the expense of the sick.
Dr. David Graham is the senior scientist within the FDA’s Office of Drug Safety. Graham became concerned when he started to see an increased number of patients having heart attacks and strokes after taking a large does of the drug Vioxx, back in 2002. He raised his concern to the FDA saying that the warning label needs to be changed due to his new findings. He had trouble getting this any attention from the FDA’s administration and decided it was time to ‘blow the whistle’ and go to the media.
The twenty-first century has seen pharmaceutical companies grow in unprecedented size and strength. Due to the unprecedented growth the larger pharmaceutical companies have gained leverage and power in the prescription drug industry, but they lack innovation to market and they seek ways to help the business continue to increase its profits. The pharmaceutical industry was once ethically sound and was a valuable player in the development of human health. However, overtime with the lack of innovation pharmaceutical companies are becoming an unethical market that exploits patients, doctors and anyone else it can to increase its profitability. With eyes only on profitability this can create a hazard for patients because there
Unfortunately, side effects are often go hand in hand with just about any drug; some more severe than others. Despite the strict regulation the FDA says it implements to ensure the highest possible safety of the drugs it approves for the public, it does pass drugs with a variety of side effects that range from dry-mouth to thoughts of suicide and potentially fatal internal problems. WebMD’s Information and Resources section explains how the FDA are able to justify this, by saying that as long
The Pharmaceutical industry has been in the spotlight for decades due to the fact that they have a reputation for being unethical in its marketing strategies. In The Washington Post Shannon Brownlee (2008) states, “We try never to forget that medicine is for the people. It is not for the profits. The profits follow.” This honorable statement is completely lost in today’s world of pharmaceutical marketing tactics. These tactics are often deceptive and biased. Big Pharma consistently forgets their moral purpose and focuses primarily on the almighty dollar. Big Pharma is working on restoring their reputation by reforming their ethical code of conduct.
Last year, in September 2004, Merck withdrawed Vioxx, off the market. Studies of Vioxx showed that it doubled the risk of a heart attack or stroke for patients who have used it more than 18 months. After Merck, withdrawed Vioxx from the market, the FDA, issued a public health advisory for the users of Vioxx. Therefore, Vioxx was on the market for five years without
While some have identified Merck as a visionary company dedicated to a "core values and a sense of purpose beyond just making money" (Collins & Porras, 2002, p. 48), others point out corporate misdeeds perpetrated by Merck (e.g., its role in establishing a dubious medical journal that republished articles favorable to Merck products) as contradictory
Do you believe that Merck acted in a socially responsible and ethical manner with regard to Vioxx? Why or why not? (In your answer, please address the company’s drug development and
Firms definitely need to incorporate their highest moral standards to build trust and reputation for themselves in order to better off in long run. Novo Nordisk always follows the regulation from Helsinki Declaration with other international ethical guidelines. They made sure that the interest and well-being of the trial subject should always transcend over the interest of science, society and commerce.
Turnaround Strategy : Merck’s research and development has not always resulted in products that provide value to consumers. Vioxx was taken off the market in 2004 when people became sick and died after taking the drug. The company’s reputation suffered after allegations that Merck asked doctors to sign Merck-written research studies for Vioxx. Merck disputes the allegation, but more than 9,200 lawsuits were filed against the company. Vioxx had generated $2.5 billion in annual sales.
In application, people might view Merck’s duties in different ways. For example, one might argue that as a company Merck only has responsibilities to release effective and safe medications and to make a profit to stay in business. On the other hand, it could be argued that as a pharmaceutical company Merck has special obligations to follow leads (like ivermectin) because they may greatly benefit human beings or save lives despite being unprofitable.
In 2000, Merck began to cooperate with Schering-Plough on several research products and in 2009 acquired their longtime partner in an effort to diversify its products and reach a broader consumer base. With challenges that include rising prices of research and prescription drugs, Merck has managed to forge forward and overcome obstacles. Merck’s survival has been a subject of speculation many times throughout the years; from the 2004 recall of their top selling drug (Vioxx) due to undesirable side effects to the recently curtailed trials of their very promising new anti-clotting drug (Vorapaxar) due to negative trial results. Kenneth Frazier, Merck’ CEO, has also come under heavy criticism due to his unconventional decision not to cut research budgets in order to increase profits. This strategy differs greatly from the usual path and it has cost Merck investor confidence which resulted in lowered stock prices . Although Merck has been subjected to challenges throughout their history they have always managed to stay afloat and maintain their reputation as a leader in healthcare.
The corporate social responsibility states that "corporations can and should act ethically and be accountable to society for their actions." Pharmaceutical companies work to save lives and make a profit. Individuals should make sure that
Costs of the decision included negative public perceptions of the firm and denial of treatment to economically disadvantaged and uninsured consumers. the decision was ethical because the benefits of new life saving drugs outweighed the costs of denial of treatment to the few. So GSK regarding to its primary stakeholders was social responsible.
Merck was established in 1891 to improve human and animal health through the development of innovative products. Merck currently has two reportable segments, the Pharmaceutical Segment and the Vaccines and Infectious Diseases Segment. Merck sells products through several channels including wholesalers, retailers, hospitals, clinics, government and managed health services providers. In the 1980’s the Merck was very successful in producing 10 major new drugs and had a very healthy pipeline. In later years, Merck has entered into joint ventures with many other pharmaceutical companies in order to expand its pipeline. In the last several years Merck has